Sandhill Capital Partners’s Matinas BioPharma MTNB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-1,000
| Closed | -$40K | – | 97 |
|
|
2022
Q1 | $40K | Hold |
1,000
| – | – | ﹤0.01% | 86 |
|
|
2021
Q4 | $50K | Sell |
1,000
-400
| -29% | -$20K | ﹤0.01% | 85 |
|
|
2021
Q3 | $91K | Buy |
1,400
+800
| +133% | +$52K | 0.01% | 89 |
|
|
2021
Q2 | $23K | Buy |
600
+200
| +50% | +$7.67K | ﹤0.01% | 86 |
|
|
2021
Q1 | $21K | Buy |
400
+200
| +100% | +$10.5K | ﹤0.01% | 81 |
|
|
2020
Q4 | $14K | Buy |
+200
| New | +$14K | ﹤0.01% | 82 |
|